ES2279139T3 - Uso de los derivados de epotilona para el tratamiento del hiperparatiroidismo. - Google Patents
Uso de los derivados de epotilona para el tratamiento del hiperparatiroidismo. Download PDFInfo
- Publication number
- ES2279139T3 ES2279139T3 ES03748446T ES03748446T ES2279139T3 ES 2279139 T3 ES2279139 T3 ES 2279139T3 ES 03748446 T ES03748446 T ES 03748446T ES 03748446 T ES03748446 T ES 03748446T ES 2279139 T3 ES2279139 T3 ES 2279139T3
- Authority
- ES
- Spain
- Prior art keywords
- parathyroid
- treatment
- lower alkyl
- hydrogen
- epothilone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41859202P | 2002-10-15 | 2002-10-15 | |
| US418592P | 2002-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2279139T3 true ES2279139T3 (es) | 2007-08-16 |
Family
ID=32107949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES03748446T Expired - Lifetime ES2279139T3 (es) | 2002-10-15 | 2003-10-13 | Uso de los derivados de epotilona para el tratamiento del hiperparatiroidismo. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20060142354A1 (enExample) |
| EP (1) | EP1553938B1 (enExample) |
| JP (1) | JP4672368B2 (enExample) |
| CN (1) | CN1297269C (enExample) |
| AT (1) | ATE350034T1 (enExample) |
| AU (1) | AU2003267751A1 (enExample) |
| BR (1) | BR0315293A (enExample) |
| CA (1) | CA2501717C (enExample) |
| CY (1) | CY1106385T1 (enExample) |
| DE (1) | DE60310975T2 (enExample) |
| DK (1) | DK1553938T3 (enExample) |
| ES (1) | ES2279139T3 (enExample) |
| PT (1) | PT1553938E (enExample) |
| SI (1) | SI1553938T1 (enExample) |
| WO (1) | WO2004035050A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| DK1767535T3 (da) | 2002-08-23 | 2010-04-12 | Sloan Kettering Inst Cancer | Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2106553T5 (es) * | 1993-07-19 | 2008-02-16 | Angiotech Pharmaceuticals, Inc. | Composiciones anti-angiogenicas y metodos de uso. |
| PT1367057E (pt) * | 1996-11-18 | 2008-12-04 | Biotechnolog Forschung Gmbh | Epotilonas e e f |
| US6380394B1 (en) * | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
| PL201329B1 (pl) * | 1998-02-05 | 2009-03-31 | Novartis Ag | Preparat farmaceutyczny w postaci koncentratu infuzyjnego |
| US6302838B1 (en) * | 1998-02-25 | 2001-10-16 | Novartis Ag | Cancer treatment with epothilones |
-
2003
- 2003-10-13 ES ES03748446T patent/ES2279139T3/es not_active Expired - Lifetime
- 2003-10-13 US US10/530,855 patent/US20060142354A1/en not_active Abandoned
- 2003-10-13 JP JP2004544592A patent/JP4672368B2/ja not_active Expired - Fee Related
- 2003-10-13 AT AT03748446T patent/ATE350034T1/de active
- 2003-10-13 DE DE60310975T patent/DE60310975T2/de not_active Expired - Lifetime
- 2003-10-13 EP EP03748446A patent/EP1553938B1/en not_active Expired - Lifetime
- 2003-10-13 AU AU2003267751A patent/AU2003267751A1/en not_active Abandoned
- 2003-10-13 PT PT03748446T patent/PT1553938E/pt unknown
- 2003-10-13 CA CA2501717A patent/CA2501717C/en not_active Expired - Fee Related
- 2003-10-13 SI SI200330741T patent/SI1553938T1/sl unknown
- 2003-10-13 CN CNB200380101281XA patent/CN1297269C/zh not_active Expired - Fee Related
- 2003-10-13 DK DK03748446T patent/DK1553938T3/da active
- 2003-10-13 WO PCT/IB2003/004514 patent/WO2004035050A1/en not_active Ceased
- 2003-10-13 BR BR0315293-6A patent/BR0315293A/pt not_active IP Right Cessation
-
2007
- 2007-03-15 CY CY20071100363T patent/CY1106385T1/el unknown
-
2011
- 2011-03-01 US US13/037,989 patent/US20110152329A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1297269C (zh) | 2007-01-31 |
| PT1553938E (pt) | 2007-03-30 |
| WO2004035050A1 (en) | 2004-04-29 |
| ATE350034T1 (de) | 2007-01-15 |
| HK1080768A1 (en) | 2006-05-04 |
| DE60310975T2 (de) | 2007-07-12 |
| AU2003267751A1 (en) | 2004-05-04 |
| DE60310975D1 (de) | 2007-02-15 |
| EP1553938B1 (en) | 2007-01-03 |
| DK1553938T3 (da) | 2007-03-26 |
| CA2501717C (en) | 2012-09-18 |
| US20060142354A1 (en) | 2006-06-29 |
| JP4672368B2 (ja) | 2011-04-20 |
| BR0315293A (pt) | 2005-08-30 |
| CY1106385T1 (el) | 2011-10-12 |
| JP2006504751A (ja) | 2006-02-09 |
| CA2501717A1 (en) | 2004-04-29 |
| SI1553938T1 (sl) | 2007-06-30 |
| US20110152329A1 (en) | 2011-06-23 |
| EP1553938A1 (en) | 2005-07-20 |
| CN1703217A (zh) | 2005-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8268837B2 (en) | Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia | |
| CA2440111A1 (en) | Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative | |
| US20090246172A1 (en) | Compositions comprising epothilones and their use for the treatment of carcinoid syndrome | |
| KR20240104138A (ko) | 니로가세스타트를 사용한 조성물 및 치료 | |
| JP5642892B2 (ja) | 多形膠芽腫の治療のためのマシテンタンを含有する組み合わせ剤 | |
| ES2330324T3 (es) | Derivados del epotilon para el tratamiento del hepatoma y de otros canceres. | |
| ES2279139T3 (es) | Uso de los derivados de epotilona para el tratamiento del hiperparatiroidismo. | |
| PT1359905E (pt) | Uso de antagonistas de mglur5 para o tratamento de estados pruriginosos | |
| JP2023509191A (ja) | 癌を治療するための組み合わせ療法 | |
| HK1080768B (en) | Use of epothilone derivatives for the treatment of hyperparathyroidism | |
| AU2002366531B2 (en) | Compositions comprising epothilones and their use for the treatment of carcinoid syndrome | |
| JPH06505740A (ja) | 卵巣癌の治療用医薬組成物 | |
| ES2715556T3 (es) | Terapia combinada con roneparstat del mieloma múltiple | |
| JP2004514683A (ja) | レバミゾール及び５−フルオロウラシルの同時投与法 | |
| HK1069983B (en) | Compositions comprising epothilones and their use for the treatment of the carcinoid syndrome | |
| ZA200404013B (en) | Compositions comprising epothilones and their use for the treatment of carcinoid syndrome. | |
| NZ615005B2 (en) | Combinations comprising macitentan for the treatment of glioblastoma multiforme |